Malalties inflamatòries i neoplàsiques dermatològiques Ramon Mª Pujol

Publicacions 2024 (81)

March-Rodriguez A^*, Alcalá R, Pujol RM. Eruptive syringomas associated with milia-like idiopathic calcinosis cutis. Pediatr Dermatol 2024: (en Premsa).
Planella-Fontanillas N^*, Rial A, Villar-García J, Parra-Navarro L, Santiago P, Pujol RM, Rodríguez-Morera J. Hepatic inflammatory pseudotumours mimicking metastatic disease in a non-HIV patient with secondary syphilis. J Eur Acad Dermatol Venereol 2024: (en Premsa).
Belinchón-Romero I^*, López-Ferrer A, Ferran M, Rivera-Diaz R, Vidal-Sarro D, Rodriguez-Fernandez-Freire L, De la Cueva-Dobao P, Santos-Juanes J, Rocamora-Durán V, Martin V, Gómez-Labrador L, Queiro-Silva R, en representación del PURE-4 Study Group. Validation of the Spanish Version of the PURE-4 Questionnaire for the Early Detection of Psoriatic Arthritis in Psoriatic Patients. Actas Dermosifiliograf 2024: (en Premsa).
Altrichter S^*, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ, ARROYO Study Investigators. Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase 2b multinational, randomised, double-blind, placebo-controlled ARROYO trial . Br J Dermatol 2024: (en Premsa).
Pesqué D^*, Borrego L, Zaragoza-Ninet V, Sanz-Sánchez T, Miquel FJ, González-Pérez R, Silvestre JF, Cordoba-Guijarro S, Carrascosa JM, Gatica-Ortega ME, Ruiz-González I, Mercader-García P, Tous-Romero F, Ortiz de Frutos FJ, Serra-Baldrich E, Pastor-Nieto MA, Rodríguez-Serna M, Sánchez Pérez J, Sánchez-Gilo A, Melé Ninot G, Sánchez-Pedreño P, Pujol RM, Giménez-Arnau AM^*. Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis. J Eur Acad Dermatol Venereol 2024: (en Premsa).
Montero-Menárguez J^*, Amat-Samaranch V, Puig-Sanz L, Ruiz-Villaverde R, Arias-Santiago S, Larrea-García M, Ruiz-Genao D, Ferran M, Schneller-Pavelescu L, Romero-Ferreiro C, Rivera-Diaz R. Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients. Actas Dermosifiliograf 2024: (en Premsa).
Maurer M^*, Casale TB, Saini SS, Ben-Shoshan M, Giménez-Arnau AM, Bernstein JA, Yagami A, Stjepanovic A, Radin A, Staudinger HW, Patel N, Amin N, Akinlade B, Fan C, Bauer D, Yancopoulos GD, Patel K, Mannent LP, Laws E. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials. J Allergy Clin Immunol 2024: (en Premsa).
Aguado-Vázquez A^*, Estébanez-Corrales A, Melgosa-Ramos FJ, Mascaró-Galy JM, Fulgencio-Barbarin J, Bosch-Amate X, Curto-Barredo L, Blanes-Martínez M, Ruíz-Villaverde R, Ballester-Martínez A, Martín-Torregrosa D, Castaño-Fernández JL, Cabeza-Martínez R, Pérez-Ferriols A, Ramos-Rodríguez D, Boix-Vilanova J, Melé Ninot G, Expósito-Serrano V, España A, Mateu-Puchades A. Efficacy of Omalizumab for the treatment of Bullous Pemphigoid. Spanish multicenter real-world experience. Clin Exp Dermatol 2024: (en Premsa).
Tejera-Vaquerizo A, Boada A, Puig S, Nagore E, Fernandez de Misa R, Ferrándiz L, Conde-Taboada A, Castro E, Richarz NA, Paradela S, Llambrich Á, Salgüero I, Diago A, Samaniego E, Flórez Á, Segura S, Maldonado-Seral C, Coronel-Pérez IM, Tomás-Velázquez A, Rodríguez P, Mayor A, García-Doval I, Grau-Pérez M^*, Grupo REGESMEL. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation. Actas Dermosifiliograf 2024: (en Premsa).
Martorell A^*, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Diaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran M, Gallardo F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Jara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study. Actas Dermosifiliograf 2024: (en Premsa).
Escolà H^*, Llombart B, Escolà-Rodríguez A, Barchino L, Marcoval J, Alacaraz I, Beà-Ardèbol S, Toll A, Miñano R, Rodríguez-Jiménez P, López-Nuñez M, Ferrandiz-Pulido C, Jaka A, Masferrer E, Aguayo-Ortiz RS, Yébenes M, Arandes-Marcocci J, Ruiz-Salas V, Turrión-Merino L, Just M, Sánchez J, Leal L, Mayo-Martinez F, Haya-Martínez L, Sandoval-Clavijo A, Greta-Dradi G, Delgado Y, Verdaguer-Faja J, Lopez-Castillo D, Pujol RM, Deza G. Treatment of extramammary Paget's disease with imiquimod in a real-life setting: a multicenter retrospective analysis in Spain. Clin Exp Dermatol 2024: (en Premsa).
Navarro-Triviño FJ, Borrego L^*, Silvestre-Salvador JF, Mercader-García P, Giménez-Arnau AM, Ortiz-de Frutos FJ, Sanz-Sánchez T, Melé Ninot G, Sánchez-Gilo A, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel J, Cordoba-Guijarro S, Rodríguez-Serna M, Ruiz-González I, Carrascosa-Carrillo JM, Gómez-de-la-Fuente E, Pastor-Nieto MA, Heras-Mendaza F, González-Pérez R, Sánchez-Pedreño P, Sánchez Pérez J, Gatica-Ortega ME, Fernández-Redondo V, Hervella M, Manrique-Martínez P, Guimaraens-Juanena D, García-Gavín J, Giménez-Arnau E, Figueras-Nart I, Curto-Barredo L, Armario-Hita JC. Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). Actas Dermosifiliograf 2024: (en Premsa).
Garbayo-Salmons P^*, Vilarrasa E, Bassas-Vila J, Mora-Fernández V, Fuertes I, Luque-Luna M, Fornons-Servent R, Martín-Ezquerra G, Aguayo-Ortiz RS, Ceravalls J, Mollet J, Gómez-Tomás A, Masferrer E, Corral-Magaña O, Matas-Nadal C, Del Estal J, Fuertes-Bailón D, Calvet J, Romaní J. Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2024: (en Premsa).
Pesqué D, Aerts O, Bizjak M, Gonçalo M, Dugonik A, Simon D, Ljubojevic-Hadzavdic S, Malinauskiene L, Wilkinson M, Czarnecka-Operacz M, Krecisz B, John SM, Balato A, Ayala F, Rustemeyer T, Giménez-Arnau AM^*. Differential diagnosis of contact dermatitis: A practical-approach review by the EADV Task Force on contact dermatitis. 2024: (en Premsa).
Pesqué D, Mensa-Vilaro A, García-Herrrera A, Planella-Fontanillas N, March-Rodriguez A, Pujol RM, Aróstegui JI, Giménez-Arnau AM^*. Low-level NLRP3 somatic mosaicism in adult-onset cryopyrin-associated periodic syndrome misdiagnosed as chronic urticaria. J Allergy Clin Immunol Pract 2024: (en Premsa).
Cherrez-Ojeda I^*, Bousquet J, Giménez-Arnau AM, Godse K, Krasowska D, Bartosinska J, Szczepanik-Kulak P, Wawrzycki B, Kolkhir P, Allenova A, Allenov A, Tkachenko S, Mitrevska NT, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zajac A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Ibrahim T, Aqel S, Pesqué D, Rodriguez-Gonzalez M, Wakida-Kuzunoki GH, Ramon GD, Ramon GN, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Fomina D, Larenas-Linnemann D, Kosnik M, Kara RO, Caballero-López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Jardim-Criado RF, Bauer A, Cherrez A, Cherrez S, Chong-Neto H, Rojo-Gutierrez MI, Rudenko M, Larco-Sousa JI, Lesiak A, Matos E, Tinoco I, Crespo-Shijin C, Hinostroza-Logroño R, Sagñay J, Faytong-Haro M, Robles-Velasco K, Zuberbier T, Maurer M^*. Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE study. J Allergy Clin Immunol Pract 2024: (en Premsa).
Abril-Pérez C, Mansilla-Polo M^*, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio Murillo E, Miñano R, Gonzalez-Sixto B, Artola Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez J, Allende Markixana I, Alonso-Pacheco ML, Garcia-Bracamonte B, De la Cueva-Dobao P, Navarro R, Ciudad C, Carnero-González L, Vázquez-Veiga H, Cano-Martinez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Florez-Menéndez A, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor Arenal M, Suarez Fernández R, Sainz-Gaspar L, Descalzo MA, García-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). J Eur Acad Dermatol Venereol 2024: (en Premsa).
Sahuquillo-Torralba A, Mansilla-Polo M^*, Pujol-Marco C, Llamas-Velasco M, Rull EV, Ruíz-Villaverde R, Ferran M, Pitarch G, Lopez A, Beltran E, Urruticoechea-Arana A, Riera-Monroig J, Alsina M, Vidal D, Belinchón-Romero I, Notario J, Carrascosa JM, Gonzalez-Delgado V, Mollet J, Ribera M, Gallardo F. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group. Int J Dermatol 2024: (en Premsa).
Mansilla-Polo M^*, Pons-Benavent M, Fernández-Crehuet P, Vilarrasa E, Albanell-Fernández C, Morales-Tedone E, Rausell-Félix F, Alcalá R, Matellanes-Palacios M, Martín-Ezquerra G, Alfageme F, Ciudad-Blanco C, López-Villaescusa MT, Garbayo-Salmons P, Martorell A, Escutia-Muñoz B, Navarro-Blanco F, Martín-Torregrosa D, Cuenca-Barrales C, Molina-Leyva A, Botella-Estrada R. Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study. Australas J Dermatol. 2024: (en Premsa).
Pechuan E, Toll A^*, Bergé D, Legido T, Martinez-Sadurni L, Trabsa A, De Iturbe G, García S, Jiménez B, Fernández A, Pérez V, Mané A. Clozapine use in the first two years after first-episode psychosis in a real-world clinical sample. 2024; 2853(24): (en Premsa).
Ciudad A, Rivera M, Pujol RM. Solitary Acute Necrotic Scrotal Ulcer in a Young Patient. JAMA Dermatol 2024: (en Premsa).
Soegiharto R^*, Alizadeh-Aghdam M, Sørensen JA, Van-Lindonk E, Bulut-Demir F, Porras NM, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Sevimli-Dikicier B, Van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation. JAMA Dermatol 2024: (en Premsa).
Verdaguer-Faja J, Guerra-Amor Á, Ferrandiz-Pulido C, Abril-Pérez C, Botella-Estrada R, Masferrer E, Lopez-Castillo D, Deza G, Leal L, Marti-Marti I, Ruiz-Salas V, Yébenes M, Marqués-Martin L, Baliu C, Castany A, Boada A, Toll A, Jaka A^*. Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence. 2024: (en Premsa).
Schwensen JFB^*, Uter W, Aerts O, Agner T, Brans R, Bruze M, Foti C, Giménez-Arnau AM, Gonçalo M, Svedman C, Stingeni L, Wilkinson M, Johansen JD, European Environmental Contact Dermatitis Research Group. Current frequency of contact allergy to isothiazolinones (methyl-, benz- and octylisothiazolinone) across Europe. Contact Dermatitis 2024: (en Premsa).
Bizjak M^*, Kosnik M, Asero R, Kocatürk E, Giménez-Arnau AM, Maurer M. Lymphopenia in Chronic Spontaneous Urticaria is Linked to Basopenia and Eosinopenia. Clin Exp Allergy 2024: (en Premsa).
Iznardo H^*, Roé E, Vicente A, Prat C, Casals M, Martin-Santiago A, Esteve A, Viñas M, Munera-Campos M, Corella F, Mollet J, Figueras-Nart I, Vila A, Soria X, Azón-Masoliver A, Marqués-Martin L, Nadal-Lladó C, Bel S, Pujol-Montcusi JA, Bertolín M, Curto-Barredo L, Melé-Ninot G, Evole M, Berbegal L, Puig L, Baselga E. Dupilumab treatment in paediatric atopic dermatitis (2 to 18 years): Spanish multicentre retrospective real-life study. Clin Exp Dermatol 2024: (en Premsa).
Chicharro P^*, Munera-Campos M, Zaragoza-Ninet V, Giménez-Arnau AM, González-Pérez R, Miquel FJ, Cordoba-Guijarro S, Sanz-Sánchez T, Ruiz-González I, Silvestre-Salvador JF, Serra-Baldrich E, Borrego L, Pastor-Nieto MA, Ortiz de Frutos FJ, Mercader-García P, Heras-Mendaza F, Fernández-Redondo V, Rodríguez-Serna M, Hervella M, Carrascosa JM, Gallego-Descalzo MA, García-Doval I, Sánchez Pérez J. Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC). Contact Dermatitis 2024: (en Premsa).
Gatica-Ortega ME^*, Pastor-Nieto MA, Giménez-Arnau AM, Mercader-García P, Serra-Baldrich E, Zaragoza-Ninet V, Sanz-Sánchez T, Sánchez-Gilo A, Pesqué D, Tous-Romero F, Ortiz-de Frutos FJ, de la Rosa-Fernández E, Dorta-Alom S, Elosua-González M, González-Pérez R, Carrascosa-Carrillo JM, Munera-Campos M, Silvestre-Salvador JF, Miquel-Miquel J, de Mateo Minguez A, Borrego L. An emerging epidemic of allergic contact dermatitis due to phytonadione epoxide (oxidised vitamin K1). Contact Dermatitis 2024: (en Premsa).
Ceravalls J^*, Pérez-Muñoz N, Sola MÁ, Gallardo F, Colomo L, Pujol RM. Asymptomatic evanescent plaques on the buttocks of an elderly woman. Int J Dermatol 2024: (en Premsa).
March-Rodriguez A^*, Lobato A, Pujol RM. Recurrent aphthous stomatitis in a child successfully treated with apremilast. Pediatr Dermatol 2024: (en Premsa).
Ceravalls J^*, Ruiz-Villaverde R, Armesto S, Fernández-Armenteros JM, Riera-Monroig J, Gracia-Cazaña T, Quintana-Codina M, Iglesias-Sancho M, Salleras M, Imbernón-Moya A, Melgosa-Ramos FJ, Ferran M. Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study. J Eur Acad Dermatol Venereol 2024: (en Premsa).
Soegiharto R^*, Alizadeh-Aghdam M, Sørensen JA, Van Lindonk E, Bulut-Demir F, Mohammad N, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Dikicier BS, Van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study. Allergy 2024: (en Premsa).
Fernández-Vela J^*, Romaní J, Martín-Ezquerra G. Lepromatous Leprosy in an Immunosuppressed Patient Due to Renal Transplantation Associated with Glucose-6-Phosphate Dehydrogenase Deficiency: A Diagnostic and Therapeutic Challenge. Indian Dermatol Online J. 2024; 15(5): 873-875 (Acceptat).
García-Jiménez I, Sans-de San Nicolas L, Curto-Barredo L, Bertolín M, Sensada-López E, Figueras-Nart I, Bonfill-Ortí M, Guilabert-Vidal A, Ryzhkova A, Ferran M, Damiani G, Czarnowicki T, Pujol RM, Santamaria-Babí LF^*. Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients. Int J Mol Sci 2024; 25(16): 8569.
Mubariki R, Samara R, Giménez-Arnau AM, Maurer M, Bejar J, Toubi E, Vadasz Z^*. CD4(+)CCR5(+) T cells and CCL3+ mast cells are increased in the skin of patients with chronic spontaneous urticaria. Front Immunol 2024; 15: 1327040 (Acceptat).
Mercader-García P^*, Silvestre JF, Navarro-Triviño FJ, Giménez-Arnau AM, Pastor-Nieto MA, Cordoba-Guijarro S, Melé Ninot G, Tous-Romero F, González-Pérez R, Ruiz-González I, Sánchez Pérez J, Gatica-Ortega ME, Sánchez-Pedreño P, Miquel-Miquel J, Ortiz-Frutos J, Carrascosa JM, Serra-Baldrich E, Sanz-Sánchez T, Soria-Aledo V, Carrillo A, Borrego L, REIDAC. A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. Contact Dermatitis 2024; 91(3): 228-236.
Lluch-Galcerá JJ, Manzanares N, Martinez-Molina M, Valdivieso L, Boada A, Segura S, Rovira R, Pujol RM, Jaka A^*. SDRIFE und bullöse Reaktion nach Behandlung mit Enfortumab Vedotin plus Pembrolizumab: Fallserie. J Dtsch Dermatol Ges 2024; 22(8): 1161-1165.
Salman A^*, Giménez-Arnau AM. Emerging Systemic Treatment Options in Atopic Dermatitis. Balkan Med J . 2024; 41(4): 239-247.
Planella-Fontanillas N^*, Pesqué D, Parra-Navarro L, Pujol RM. A 71-year-old Woman with CREST Syndrome and Multiple Waxy Facial Papules and Plaques: A Quiz. Acta Derm-Venereol 2024; 104: adv40419.
Zuberbier T^*, Ensina LF, Giménez-Arnau AM, Grattan C, Kocatürk E, Kulthanan K, Kolkhir P, Maurer M. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment. Lancet 2024; 404(10450): 393-404.
Pyatilova P, Hackler Y, Aulenbacher F, Asero R, Bauer A, Bizjak M, Day C, Dissemond J, Du-Thanh A, Fomina D, Giménez-Arnau AM, Grattan C, Gregoriou S, Hawro T, Kasperska-Zajac A, Khoshkhui M, Kocatürk E, Kovalkova E, Kulthanan K, Kuznetsova E, Makris M, Mukhina O, Pesqué D, Peter J, Salameh P, Siebenhaar F, Sikora A, Staubach P, Tuchinda P, Zamlynski M, Weller K, Maurer M, Kolkhir P^*. Non-Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry. J Allergy Clin Immunol Pract 2024; 12(7): 1890-1899.
Giordano S^*, Alamon-Reig F, Luque-Luna M, Castillo P, Toll A, Carrera C. Perianal Basal Cell Carcinoma: A Diagnostic Challenge. Dermatol Pract Concept 2024; 14(3): e2024195.
Dauden E^*, Belinchón I, Colominas-González E, Coto P, de la Cueva P, Gallardo F, Poveda JL, Ramírez E, Ros S, Ruíz-Villaverde R, Comellas M, Lizán L. Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Sci Rep 2024; 14(1): 14519.
Cherrez-Ojeda I^*, Bousquet J, Giménez-Arnau AM, Godse K, Krasowska D, Bartosinska J, Szcsepanik-Kulak P, Wawrzycki B, Kolkhir P, Allenova A, Allenova A, Tkachenko S, Teovska-Mitrevska N, Mijakoski D, Stoleski S, Kolacinska-Flont M, Kuprys-Lipinska I, Molinska J, Kasperska-Zajac A, Zajac M, Zamlynski M, Mihaltan F, Ulmeanu R, Zalewska-Janowska A, Tomaszewska K, Al-Ahmad M, Al-Nesf MA, Ibrahim T, Aqel S, Pesqué D, Rodriguez-Gonzalez M, Wakida-Kuzunoki GH, Ramon G, Ramon G, Neisinger S, Bonnekoh H, Rukhadze M, Khoshkhui M, Fomina D, Larenas-Linnemann D, Kosnik M, Oztas-Kara R, Caballero-López CG, Liu Q, Ivancevich JC, Ensina LF, Rosario N, Kvedariene V, Ben-Shoshan M, Criado RFJ, Bauer A, Cherrez A, Chong-Neto H, Rojo-Gutierrez MI, Rudenko M, Larco-Sousa JI, Lesiak A, Matos E, Muñoz N, Tinoco I, Moreno J, Crespo-Shijin C, Hinostroza-Logroño R, Sagñay J, Faytong-Haro M, Robles-Velasco K, Zuberbier T, Maurer M^*. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice. J Allergy Clin Immunol 2024; 12(6): 1575-1583.
Sanz-Sánchez T^*, Giménez-Arnau AM, Mercader-García P, González-Pérez R, Zaragoza-Ninet V, Miquel-Miquel J, Silvestre-Salvador JF, Cordoba-Guijarro S, Carrascosa-Carrillo JM, Gatica-Ortega ME, Ruiz-González I, Tous-Romero F, Ortiz-de Frutos FJ, Serra-Baldrich E, Pastor-Nieto A, Rodríguez-Serna M, Sánchez Pérez J, Sánchez-Gilo A, Melé Ninot G, Sánchez-Pedreño-Guillen P, García-Doval I, Borrego L. Sodium metabisulfite a current low relevant allergen in Spain. J Eur Acad Dermatol Venereol 2024; 38(6): e504-e506.
Verdaguer-Faja J^*, Borrego L, Mercader-García P, González-Pérez R, Cordoba-Guijarro S, Giménez-Arnau AM, Ruiz-González I, Miquel-Miquel J, Silvestre JF, Ortiz de Frutos FJ, Tous-Romero F, Sanz-Sánchez T, Rodríguez-Serna M, Sánchez Pérez J, Serra-Baldrich E, Zaragoza-Ninet V, Pastor-Nieto MA, Gatica-Ortega ME, Sánchez-Gilo A, Melé-Ninot G, Sánchez-Pedreño P, Munera-Campos M, Descalzo MÁ, García-Doval I, Carrascosa JM. Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermosifiliograf 2024; 115(6): 539-546.
Hosgören-Tekin S, Eyüboglu IP, Akkiprik M, Giménez-Arnau AM, Salman A^*. Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria. Arch Dermatol Res 2024; 316(6): 261.
Lluch-Galcerá JJ, Manzanares N, Martinez-Molina M, Valdivieso L, Boada A, Segura S, Rovira-López R, Pujol RM, Jaka A^*. SDRIFE and bullous reaction after treatment with enfortumab vedotin plus pembrolizumab: Case series. J Dtsch Dermatol Ges 2024: (en Premsa).
Gatica-Ortega ME^*, Pastor-Nieto MA, Giménez-Arnau AM, Mercader-García P, Sanz-Sánchez T, Carrascosa-Carrillo JM, Cordoba-Guijarro S, Sánchez Pérez J, Silvestre JF, Ortiz-de Frutos FJ, Tous-Romero F, Fernández-Redondo V, Serra-Baldrich E, Ruiz-González I, González-Pérez R, Miquel-Miquel J, Sánchez-Pedreño P, Hervella M, Heras-Mendaza F, Gómez-de-la-Fuente E, Zaragoza-Ninet V, Sánchez-Gilo A, Rodríguez-Serna M, Melé Ninot G, Descalzo MÁ, de Vega M, García-Doval I, Borrego L. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?. Contact Dermatitis 2024; 90(5): 507-513.
Hernández-Fernández CP^*, Borrego L, Giménez-Arnau AM, Zaragoza-Ninet V, Sanz-Sánchez T, Miquel FJ, González-Pérez R, Silvestre-Salvador JF, Cordoba-Guijarro S, Carrascosa-Carrillo JM, Gatica-Ortega ME, Ruiz-González I, Mercader-García P, Tous-Romero F, Serra-Baldrich E, Pastor-Nieto MA, Rodríguez-Serna M, Sánchez Pérez J, Sánchez-Gilo A, Melé-Ninot G, Sánchez-Pedreño P, de Vega-Martinez M, Gallego-Descalzo MA, García-Doval I. Sensitization to textile dyes in Spain: Epidemiological situation (2019-2022). Contact Dermatitis 2024; 90(5): 486-494.
Couselo-Rodríguez C^*, Batalla A, Carrascosa JM, Chicharro P, Gonzalez-Quesada A, de la Cueva P, Giménez-Arnau AM, Gilaberte Y, Rodríguez-Serna M, Montero-Vilchez T, Ruiz-Villaverde R, Elosua-González M, Silvestre-Salvador JF, Munera-Campos M, Sánchez Pérez J, Carretero G, Mauleón-Fernández C, Curto-Barredo L, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Navarro-Triviño FJ, Rouston-Gullon G, Betlloch I, Del Alcázar E, Abalde-Pintos MT, Suarez-Perez J, García-Doval I, Descalzo MÁ, Flórez Á. [Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermosifiliograf 2024; 115(4): T341-T346.
Rovira-López R, Pérez-Jurado L, Pujol RM. Macrocheilia as an Atypical Clinical Presentation of Capillary Malformation-Arteriovenous Malformation Type 2. JAMA Dermatol 2024; 160(4): 474-476.
Couselo-Rodríguez C^*, Batalla A, Carrascosa JM, Chicharro P, Gonzalez-Quesada A, de la Cueva P, Giménez-Arnau AM, Gilaberte Y, Rodríguez-Serna M, Montero-Vilchez T, Ruíz-Villaverde R, Elosua-González M, Silvestre-Salvador JF, Munera-Campos M, Sánchez Pérez J, Carretero G, Mauleón-Fernández C, Curto-Barredo L, Ballano-Ruiz A, Botella-Estrada R, Arias-Santiago S, Navarro-Triviño FJ, Rouston-Gullon G, Betlloch I, Del Alcázar E, Abalde-Pintos MT, Suarez-Perez J, García-Doval I, Descalzo MÁ, Flórez Á. Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermosifiliograf 2024; 115(4): 341-346.
Pesqué D, Curto-Barredo L, Pastor-Nieto MA, Pujol RM, Giménez-Arnau AM^*. Allergic Contact Dermatitis due to Over-the-Counter Antifungal Nail Brush: Is Resacetophenone an Under-Recognized Allergen?. Dermatitis 2024; 35(2): 190-191.
Lobato A^*, Escolà-Rodríguez A, Courtney A, Chim I, Ruiz-Villaverde R, Imbernón-Moya A, Velasco-Tamariz V, Vañó-Galvan S, Gil-Redondo R, Del Boz J, Garnacho G, Starace M, Saceda-Corralo D, Quadrelli F, Piraccini BM, Pujol RM. Acne keloidalis nuchae: An international multicentric review of 79 patients. 2024; 38(4): e342-e345.
Tous-Romero F^*, Borrego L, García-Doval I, Mercader-García P, Silvester-Salvador JF, Sánchez-Gilo A, Sanz-Sánchez T, Giménez-Arnau AM, Zaragoza-Ninet V, Miquel-Miquel J, González-Pérez R, Cordoba-Guijarro S, Carrascosa-Carrillo JM, Gatica-Ortega ME, Ruiz-González I, Serra-Baldrich E, Pastor-Nieto A, Rodríguez-Serna M, Sánchez Pérez J, Melé-Ninot I, Sánchez-Pedreño P, Ortiz-de Frutos FJ. Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends. Actas Dermosifiliograf 2024; 115(4): 331-340.
Pesqué D, Ciudad A, Andrades E, Soto D, Gimeno R, Pujol RM, Giménez-Arnau AM^*. Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes. Acta Derm-Venereol 2024; 104: adv25576.
Abarzua-Araya A, Bañuls J, Cabo H, Carrera C, Gamo R, González S, Jaimes N, Navarrete-Dechent C, Pérez-Anker A, Roldán-Marín R, Segura S, Yélamos O, Puig S^*, Malvehy J. [Translated article] Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study. Actas Dermosifiliograf 2024; 115(3): T258-T264.
Abarzua-Araya A, Bañuls J, Cabo H, Carrera C, Gamo R, González S, Jaimes N, Navarrete-Dechent C, Pérez-Anker A, Roldán-Marín R, Segura S, Yélamos O, Puig S^*, Malvehy J. Reflectance Confocal Microscopy Terminology in Spanish: A Delphi Consensus Study. Actas Dermosifiliograf 2024; 115(3): 258-264.
Melé Ninot G^*, Curto-Barredo L, Bonfill-Ortí M, Expósito-Serrano V, Munera-Campos M, Figueras Nart I, Riquelme-Mc Loughlin C, Gómez S, Spertino J, Serra-Baldrich E. Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis. Australas J Dermatol. 2024; 65(2): 153-162.
Lluch-Galcerá JJ, Carrascosa JM^*, Gonzalez-Quesada A, Rivera-Diaz R, Sahuquillo-Torralba A, Llamas-Velasco M, Gómez-García FJ, Herrera-Acosta E, de la Cueva P, Baniandrés-Rodríguez O, Lopez-Estebaranz JL, Belinchón I, Ferran M, Mateu-Puchades A, Rodriguez L, Riera-Monroig J, Abalde-Pintos MT, Carretero G, García-Donoso C, Pujol-Marco C, Del Alcázar E, Santamaria-Domínguez C, Suarez-Perez J, Nieto-Benito LM, Ruiz-Genao DP, Salgado-Boquete L, Descalzo MÁ, García-Doval I. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry. Br J Dermatol 2024; 190(3): 355-363.
Türk M, Kocatürk E, Ertas R, Ensina LF, Mariel-Ferrucci S, Grattan C, Vestergaard C, Zuberbier T, Maurer M^*, Giménez-Arnau AM. A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study. Clin Transl Allergy 2024; 14(2): e12343.
Wollenberg A, Giménez-Arnau AM, Stennevin A^*, Ortiz-Brugués A. Real-world effectiveness and tolerability of a cream containing postbiotic Aquaphilus dolomiae extract-G3 in subjects with sensitive facial skin. Eur J Dermatol 2024; 34(1): 79-88.
Giménez-Arnau AM^*, Salman A, Podder I^*. Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review. Eur J Dermatol 2024; 34(1): 3-12.
Lobato A^*, Pujol RM. Oral Condyloma Lata in Secondary Syphilis With Kissing Distribution. Actas Dermosifiliograf 2024; 115(2): T183.
Blanco G, Lopez-Aventin D, Pujol RM, Gómez-Llonin A, Puiggros A, Lopez-Sanchez M, Estrach T, García-Muret MP, López-Lerma I, Servitje O, Bellosillo B, Muro M, Espinet B, Rabionet R, Gallardo F^*. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. J Clin Lab Anal 2024; 37(23-24): e24982.
March-Rodriguez A^*, Escolà H, Lobato A, Curto-Barredo L, Pujol RM. Woolly hair nevus type 1 caused by somatic HRAS p.A59T mutation. Int J Dermatol 2024; 63(1): 135-136.
Neisinger S^*, Sousa-Pinto B, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Cherrez-Ojeda I, Giménez-Arnau AM, Maurer M. CRUSE - What the first 100 days have taught us. Qatar Med J . 2024; 2023(2): 14 (Acceptat).
Lobato A^*, Pujol RM. Oral condyloma lata in secondary syphilis with kissing distribution. Actas Dermosifiliograf 2024; 115(2): 183.
Navarro-Matilla B, Ortiz-Romero P.L, Pujol RM, Combalia-Escudero A, Zapata-Paz I, González-Barca E, Muniesa-Montserrat C, Morillo-Andújar M, Pérez-Ferriols A, Román-Curto C, Fernández de Misa-Cabrera R, Hospital-Gil M, Marín-Niebla A, Rios-Rull PJ, de la Cruz F, Izu-Belloso RM, Martin A, Parera E, Cordoba-Mascuñano R, Ramón-Quiles MD, Saus-Carreres A, del Campo R, Machan S, Viguera-Ester P, Blanco-Garnelo J^*. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage. Actas Dermosifiliograf 2024; 115(2): 119-129.
Jain V^*, Giménez-Arnau AM, Hayama K, Reich A, Carr W, Tillinghast J, Dahale S, Lheritier K, Walsh P, Zharkov A, Hugot S, Haemmerle S. Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks. J Allergy Clin Immunol 2024; 153(2): 479-486.e4.
Jacques-Aviñó C^*, Alarcón-Guitiérrez M, Barbera MJ, Fuertes I, Martín-Ezquerra G, López-Contreras J, Vives Á, Rodriguez R, Ros M, Rius C, Garcia-de Olalla P. Epidemiological Characteristics and Factors Associated with Repeat Sexually Transmitted Infections in Barcelona, Spain Over a Decade. Arch Sex Behav 2024; 53(2): 735-744.
Lobato A^*, López-Trujillo E, Pujol RM. Tufted Hair Follicles Associated With Lipedematous Alopecia: Magnetic Resonance Imaging and Ultrasounds Assessment. Actas Dermosifiliograf 2024; 115(2): T198-T199.
Maurer M, Albuquerque M, Boursiquot JN, Dery E, Giménez-Arnau AM, Godse K, Guitiérrez G, Kanani A, Lacuesta G, McCarthy J, Nigen S, Winders T^*. A Patient Charter for Chronic Urticaria. Adv Ther 2024; 41(1): 14-33.
Neisinger S^*, Sousa-Pinto B, Ramanauskaite A, Bousquet J, Weller K, Metz M, Magerl M, Kocatürk E, Cherrez-Ojeda I, Giménez-Arnau AM, Parisi CAS, Altrichter S, Ensina LF, Bouillet L, Asero R, Gonçalo M, Guillet C, Rutkowski K, Bernstein JA, Hardin H, Godse K, Brzoza Z, Larco-Sousa JI, Francis-Thomsen S, van Doorn M, Hide M, Ye YM, Vandersee S, Lapiņa L, Peter J, Zhao Z, Han L, Nasr I, Rockmann-helmbach H, Sørensen JA, Oztas-Kara R, Kurjāne N, Kurchenko AI, Kaidashev I, Tsaryk V, Stepanenko R, Maurer M. CRUSE(®) -An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria. Clin Transl Allergy 2024; 14(1): 12328.
Maurer M^*, Ensina LF, Giménez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T, PEARL-1 and PEARL-2 trial investigators. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials. Lancet 2024; 403(10422): 147-159.
López-Trujillo E^*, Segura S, Sánchez J. Painful Hemorrhage of Vestibular Papillae: A Probably Underreported Complication of Vestibular Papillomatosis. Dermatol Pract Concept 2024; 14(1): e2024015.
Vilarrasa E, Nicolau J, de la Cueva P, Goday A, Gallardo F, Martorell A^*, Carrascosa JM. Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases. Actas Dermosifiliograf 2024; 115(1): 56-65.
Sans-de San Nicolas L, Czarnowicki T, Akdis M, Pujol RM, Lozano-Ojalvo D, Leung DYM, Guttman-Yassky E, Santamaria-Babí LF^*. CLA+ memory T cells in atopic dermatitis. Allergy 2024; 79(1): 15-25.
Manzanares N, Vilarrasa E, Lopez A, Alonso ML, Velasco M, Riera J, Del Alcázar E, Carrascosa JM, Azón A, Rivera R, Santos S, Salgado-Boquete L, Roncero M, Dorado M, Yelamos O, Delgado C, Gallardo F, Ferran M^*. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: multicenter case series of 35 patients. J Eur Acad Dermatol Venereol 2024; 38(1): e26-e28.
Escolà H^*, Llombart B, Escolà-Rodríguez A, Barchino L, Marcoval J, Alacaraz I, Beà-Ardèbol S, Toll A, Miñano R, Rodríguez-Jiménez P, López-Nuñez M, Ferrandiz-Pulido C, Jaka A, Masferrer E, Aguayo-Ortiz RS, Yébenes M, Arandes-Marcocci J, Ruiz-Salas V, Turrión-Merino L, Just M, Sánchez J, Leal L, Mayo-Martinez F, Haya-Martínez L, Sandoval-Clavijo A, Dradi GG, Delgado Y, Verdaguer-Faja J, Lopez-Castillo D, Pujol RM, Deza G. Therapeutic Outcomes and Survival Analysis of Extramammary Paget's Disease: A multicentre retrospective study of 249 patients. J Am Acad Dermatol 2024; 90(1): 66-73.

Contacte

Coordinador:
Ramón Maria Pujol(ELIMINAR)

Tel:
93 248 33 27

Fax:
93 248 33 28

Pg Marítim, 25-29
08003 Barcelona

Vincles relacionats

Servei de Dermatologia. Hospital del Mar